Bio-Techne Stock Jumps 20% After Merck KGaA Agrees to $11.3B Acquisition
Mondeum Capital (UK) Limited
Bio-Techne shares jumped 20% to $70.58 in premarket trading on Thursday after Germany’s Merck KGaA said it would buy the life science tools company for $73 per share, which is 24% higher than Wednesday’s closing price. The deal values Bio-Techne at about $11.3 billion and is expected to close later this year or in early 2027. Here is what Merck KGaA is acquiring and how the deal fits its life sciences strategy.
Bio-Techne makes analytical technologies and lab tools that researchers and drug makers use throughout the life sciences industry. Its products help with drug discovery, development, and manufacturing, so the company supplies both academic research centers and pharmaceutical firms.
Merck KGaA said the deal will strengthen its position in some of the fastest-growing parts of life sciences and build on its experience in the field. The company’s life sciences division already works in lab reagents, instruments, and bioprocessing. Buying Bio-Techne will expand its reach into analytical technology and research tools.
The 24% premium shows how much Merck KGaA values Bio-Techne’s strengths and highlights the strong competition among life science tool providers. This sector has seen steady deal activity as bigger healthcare and industrial companies look to get involved in the research and biopharma supply chain.
Featured Courses
Recent news
OpenAI Weighs 5% U.S. Government Stake Ahead of Blockbuster IPO
OpenAI has held discussions about offering the U.S. government a 5% ownership stake, potentially structured through a sovereign wealth fund, according to a Financial Times report citing people familiar with the matter. The ChatGPT maker did not immediately respond to a request for comment. The move would add Washington to an already formidable roster of […]
Tesla Deliveries Loom as Investors Bet on Second Straight Quarterly Gain
Tesla is poised to report second-quarter delivery figures Thursday morning, capping a period marked by geopolitical conflict, a spike in oil prices, and continued fallout from shifting U.S. electric-vehicle policy. The automaker’s shares have rallied sharply ahead of the report, a signal that investors anticipate a strong outcome. Even so, forecasts vary widely enough that […]
Nvidia Stock Trails Chip Peers in First Half as Competition Broadens
Nvidia shares rose 0.4% to $195.75 in premarket trading on Tuesday, ending a first half that trailed the broader semiconductor sector. The stock is up 4.5% for the year through Monday, much less than the PHLX Semiconductor Index’s 94% gain over the same period. Here’s a look at why Nvidia has underperformed and what investors […]
Trade with fewer limits
Day trade with fewer limits at fast speed. Buy stocks and ETFs at low fees.